The Use of Therapeutic Drug Monitoring to Optimise Immunosuppressive Therapy
- 1 February 1996
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 30 (2) , 107-140
- https://doi.org/10.2165/00003088-199630020-00003
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- The mechanism of action of cyclosporin A and FK506Published by Elsevier ,2003
- Pharmacodynamic Monitoring of CyclosporinClinical Pharmacokinetics, 1992
- Optimization of Sampling Time for Cyclosporine Monitoring in Transplant PatientsThe Journal of Clinical Pharmacology, 1992
- A Review of Assay Methods for CyclosporinClinical Pharmacokinetics, 1992
- Specific Enzyme-Multiplied Immunoassay and Fluorescence Polarization Immunoassay for Cyclosporin Compared with Cyclotrac [125I]RadioimmunoassayTherapeutic Drug Monitoring, 1992
- Pharmacokinetic strategies for cyclosporin therapy in organ transplantationJournal of Autoimmunity, 1992
- Cyclosporin monitoring: Its role in autoimmune indicationsJournal of Autoimmunity, 1992
- Area Under the Curve Monitoring of Cyclosporine TherapyTherapeutic Drug Monitoring, 1991
- A Preliminary Study to Evaluate an In Vitro Assay for Determining Patient Whole Blood Immunosuppressive Cyclosporine A and Metabolite ActivityTherapeutic Drug Monitoring, 1991
- Measurement of Cyclosporine in Plasma of Cardiac Allograft Recipients by Fluorescence Polarization ImmunoassayTherapeutic Drug Monitoring, 1990